Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2020081340 - IMAGE ENHANCEMENT TO ENABLE IMPROVED NUCLEI DETECTION AND SEGMENTATION


Disclaimer The image version (PDF) available on PATENTSCOPE is the official version. This online html version is provided to assist users. Despite the great care taken in its compilation to ensure a precise and accurate representation of the data appearing on the printed document/images, errors and/or omissions cannot be excluded due to the data transmittal, conversion and inherent limitations of the (optional) machine translation processes used. Hyperlinks followed by this symbol , are to external resources that are not controlled by WIPO. WIPO disclaims all liability regarding the above points.

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/US2019/055529 Ventana-0134WOP349
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
10 October 2019 15 October 2018
Applicant
VENTANA MEDICAL SYSTEMS, INC.
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No.     3B    
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     G06T 7/00 (2017.01)i; G06K 9/00 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     G06T; G06K
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
X
WO 2012016242 A2 (AUREON BIOSCIENCES INC [US]; AJEMBA PETER [US] ET AL.) 02 February 2012 (2012-02-02)
1-7,9-15,21-34
Y
abstract
12-21,26,29,32-35
A
paragraphs [0006], [0007], [0009], [0036], [0092], [0096], [0138], [0139]
8
(2)
X
AJEMBA PETER ET AL, "Integrated segmentation of cellular structures", MEDICAL IMAGING 2011: IMAGE PROCESSING, SPIE, 1000 20TH ST. BELLINGHAM WA 98225-6705 USA,Vol. 7962, No. 1, 03 March 2011 (2011-03-03), page 1-10,
XP060009387
1-7,9-11,16,22-25,27,28,30,31
Y
abstract; figure 3
12-21,26,29,32-35
A
sections 2.1 Materials; 2.2 Methods
8
(3)
Y
Ali Can ET AL, "Techniques for Cellular Quantitation of Cancer Biomarkers", "Analytical Chemistry", page 1-29, 01 June 2018 (2018-06-01), USAmerican Chemical Society,
XP055540751
12-15,17-19,26,29,32
section: Image Analysis;page 6
(4)
Y
US 8995740 B2 (GEN ELECTRIC [US]) 31 March 2015 (2015-03-31)
12,17-19,26,29,32
abstract
column 10, line 40 - line 42
(5)
A
HODNELAND E ET AL, "A Unified Framework for Automated 3-D Segmentation of Surface-Stained Living Cells and a Comprehensive Segmentation Evaluation", IEEE TRANSACTIONS ON MEDICAL IMAGING, IEEE SERVICE CENTER, PISCATAWAY, NJ, US,Vol. 28, No. 5, 01 May 2009 (2009-05-01), page 720-738,
XP011249670
1,8,22,31
abstract
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"D"
document cited by the applicant in the international application
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family

D. INFORMATION ON PATENT FAMILY MEMBERS

Patent document cited in search report Publication date
(day/month/year)
Patent family member(s) Publication date
(day/month/year)
WO 2012016242 A2
02 February 2012
CA 2807144 A1
CA 3010836 A1
CA 3048769 A1
EP 2599055 A2
EP 2779089 A2
ES 2711196 T3
PT 2779089 T
US 2013230230 A1
US 2016188954 A1
US 2018025212 A1
WO 2012016242 A2
02 February 2012
02 February 2012
02 February 2012
05 June 2013
17 September 2014
30 April 2019
19 February 2019
05 September 2013
30 June 2016
25 January 2018
02 February 2012
US 8995740 B2
31 March 2015
CN 105122308 A
EP 2987142 A1
JP 6496709 B2
JP 2016517115 A
US 2014314299 A1
WO 2014172527 A1
02 December 2015
24 February 2016
03 April 2019
09 June 2016
23 October 2014
23 October 2014
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
10 December 2019
Date of mailing of the international search report:
18 December 2019
Authorized officer:
Rimassa, Simone
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E